Literature DB >> 25308387

Challenges and strategies in helping the DSM become more dimensional and empirically based.

Robert F Krueger1, Christopher J Hopwood, Aidan G C Wright, Kristian E Markon.   

Abstract

The DSM-5 creation process and outcome underlines a core tension in psychiatry between empirical evidence that mental pathologies tend to be dimensional and a historical emphasis on delineating categorical disorders to frame psychiatric thinking. The DSM has been slow to reflect dimensional evidence because doing so is often perceived as a disruptive paradigm shift. As a result, other authorities are making this shift, circumventing the DSM in the process. For example, through the Research Domain Criteria (RDoC), NIMH now encourages investigators to focus on a dimensional and neuroscientific conceptualization of mental disorder research. Fortunately, the DSM-5 contains a dimensional model of maladaptive personality traits that provides clinical descriptors that align conceptually with the neuroscience-based dimensions delineated in the RDoC and in basic science research. Through frameworks such as the DSM-5 trait model, the DSM can evolve to better incorporate evidence of the dimensionality of mental disorder.

Entities:  

Mesh:

Year:  2014        PMID: 25308387     DOI: 10.1007/s11920-014-0515-3

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  25 in total

Review 1.  Categories versus dimensions in personality and psychopathology: a quantitative review of taxometric research.

Authors:  N Haslam; E Holland; P Kuppens
Journal:  Psychol Med       Date:  2011-09-23       Impact factor: 7.723

2.  Comorbidity and Chairman Mao.

Authors:  Scott O Lilienfeld; Irwin D Waldman
Journal:  World Psychiatry       Date:  2004-02       Impact factor: 49.548

Review 3.  The development of personality disorders: perspectives from normal personality development in childhood and adolescence.

Authors:  Rebecca L Shiner
Journal:  Dev Psychopathol       Date:  2009

Review 4.  Personality disorder research agenda for the DSM-V.

Authors:  Thomas A Widiger; Erik Simonsen; Robert Krueger; W John Livesley; Roel Verheul
Journal:  J Pers Disord       Date:  2005-06

5.  Current and lifetime comorbidity of the DSM-IV anxiety and mood disorders in a large clinical sample.

Authors:  T A Brown; L A Campbell; C L Lehman; J R Grisham; R B Mancill
Journal:  J Abnorm Psychol       Date:  2001-11

6.  A comparison of latent class, latent trait, and factor mixture models of DSM-IV borderline personality disorder criteria in a community setting: implications for DSM-5.

Authors:  Christopher Conway; Constance Hammen; Patricia Brennan
Journal:  J Pers Disord       Date:  2012-10

7.  Clinical utility: a prerequisite for the adoption of a dimensional approach in DSM.

Authors:  Michael B First
Journal:  J Abnorm Psychol       Date:  2005-11

8.  Does a latent class underlie schizotypal personality disorder? Implications for schizophrenia.

Authors:  Anthony O Ahmed; Bradley A Green; Nada M Goodrum; Nancy J Doane; Denis Birgenheir; Peter F Buckley
Journal:  J Abnorm Psychol       Date:  2013-05

9.  The boundaries of the internalizing and externalizing genetic spectra in men and women.

Authors:  K S Kendler; J Myers
Journal:  Psychol Med       Date:  2013-04-11       Impact factor: 7.723

Review 10.  Dimensional models of personality: the five-factor model and the DSM-5.

Authors:  Timothy J Trull; Thomas A Widiger
Journal:  Dialogues Clin Neurosci       Date:  2013-06       Impact factor: 5.986

View more
  10 in total

1.  The alternative DSM-5 model for personality disorders.

Authors:  John M Oldham
Journal:  World Psychiatry       Date:  2015-06       Impact factor: 49.548

Review 2.  Irritability in Pediatric Patients: Normal or Not?

Authors:  Usman Hameed; Cheryl A Dellasega
Journal:  Prim Care Companion CNS Disord       Date:  2016-03-24

Review 3.  Advancing the study of sluggish cognitive tempo via DSM, RDoC, and hierarchical models of psychopathology.

Authors:  Stephen P Becker; Erik G Willcutt
Journal:  Eur Child Adolesc Psychiatry       Date:  2018-03-10       Impact factor: 4.785

4.  Dual Diagnosis: A Problematic Construct When Applied to Persons with Intellectual Disabilities.

Authors:  John D McLennan
Journal:  Can J Psychiatry       Date:  2018-04-19       Impact factor: 4.356

5.  Construct Validity of the PHQ-9 Depression Screen: Correlations with Substantive Scales of the MMPI-2-RF.

Authors:  David M McCord; Randall P Provost
Journal:  J Clin Psychol Med Settings       Date:  2020-03

6.  Targets and outcomes of psychotherapies for mental disorders: an overview.

Authors:  Pim Cuijpers
Journal:  World Psychiatry       Date:  2019-10       Impact factor: 49.548

7.  The association of unplanned pregnancy with perinatal depression: a longitudinal cohort study.

Authors:  Lotte Muskens; Myrthe G B M Boekhorst; Willem J Kop; Marion I van den Heuvel; Victor J M Pop; Annemerle Beerthuizen
Journal:  Arch Womens Ment Health       Date:  2022-03-26       Impact factor: 4.405

8.  Poor Separation of Clinical Symptom Profiles by DSM-5 Disorder Criteria.

Authors:  Jennifer Jane Newson; Vladyslav Pastukh; Tara C Thiagarajan
Journal:  Front Psychiatry       Date:  2021-11-29       Impact factor: 4.157

9.  Applying the DSM-5 Alternative Model of Personality Disorders and the Shedler-Westen Assessment Procedure to the Classic Case of "Madeline G.": Novice and Expert Rater Convergences and Divergence.

Authors:  Alisa R Garner; Natalie Blocher; David Tierney; Megan Baumgardner; Alayna Watson; Gloria Romero; Rebecca Skadberg; Taylor Younginer; Mark H Waugh
Journal:  Front Psychol       Date:  2022-02-15

10.  Assessment of personality-related levels of functioning: a pilot study of clinical assessment of the DSM-5 level of personality functioning based on a semi-structured interview.

Authors:  Birgitte Thylstrup; Sebastian Simonsen; Caroline Nemery; Erik Simonsen; Jane Fjernestad Noll; Mikkel Wanting Myatt; Morten Hesse
Journal:  BMC Psychiatry       Date:  2016-08-25       Impact factor: 3.630

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.